Seroprevalence of SARS-CoV-2 antibodies and retrospective mortality in two African settings: Lubumbashi, Democratic Republic of the Congo and Abidjan, Côte d’Ivoire

enthalten in: bioRxiv.org | 2024

von Simons, E. | Nikolay, B. | Ouedraogo, P. | +24

Breakthrough treatments for Ebola virus disease, but no access-what went wrong, and how can we do better?

enthalten in: The Lancet. Infectious diseases | 2023

von Torreele, E. | Boum, Y. | Adjaho, I. | +5

On the importance and challenges of global access to proven life-saving treatments for Ebolavirus - Authors' reply

enthalten in: The Lancet. Infectious diseases | 2023

von Torreele, E. | Boum, Y. | Adjaho, I. | +5

Seroprevalence of SARS-CoV-2 antibodies and retrospective mortality in two African settings : Lubumbashi, Democratic Republic of the Congo and Abidjan, Côte d'Ivoire

enthalten in: PLOS global public health | 2023

von Simons, E. | Nikolay, B. | Ouedraogo, P. | +24